Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.43
Delayed Data
As of Mar 04
 +0.05 / +2.10%
Today’s Change
2.18
Today|||52-Week Range
6.60
-8.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization143.0K168.0K169.0K167.0K
 
 
 
 
 
 
Operating ExpensesGross Income---168.0K-169.0K-167.0K
 
 
 
 
General Expenses23.3M22.7M21.5M19.3M
 
 
 
 
 
Research And Development20.0M17.6M18.8M16.2M
 
 
 
 
 
Total Operating Expenses23.4M22.9M21.7M19.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.4M-22.9M-21.7M-19.4M
 
 
 
 
 
Interest Expense On Debt718.0K650.0K585.0K517.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.2M-23.6M-22.3M-20.0M
 
 
 
 
 
Net Income-24.2M-23.6M-22.3M-20.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS76.8M85.4M94.0M105.8M
 
 
 
 
 
Shares To Calculate EPS Diluted76.8M85.4M94.0M105.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.28-$0.24-$0.19
 
 
 
 
 
EPS Diluted-$0.31-$0.28-$0.24-$0.19
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account